Welcome to Nigeria Clinical Trials Registry

You will need to Register as a Nurse or Consultant before you are allowed access. If you are already registered, simply login with your email address and your password

Member Login

Don't Have Account? Click here to create one

Password Reset Request

Enter your email Address to get a new password!

Nigeria Clinical Trials Registry
NigeriaClinical Trials Registry

Because of ethical and scientific reasons, NCTR is established for registering trials. There will be Open access to information about ongoing and completed trials

Learn More

Quick Info!



Search for Studies. Example: "Breast Cancer"

You searched for ebola

2 results found !

  • 39808518
  • 202091 (EBOLA Z CHAD3-005):Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in adults in Africa
  • Using the investigational EBOV vaccine encoded by chimpanzee-derived adenovirus (ChAd3-EBO-Z) dose selected during the Phase 1 stage, the present Phase 2, randomised, placebo-controlled trial will aim at collecting robust safety and immunogenicity data following a single intramuscular (IM) dose of the investigational ChAd3-EBO-Z vaccine.
  • 2017-09-18
  • 26989548
  • Safety and immunogenicity study of GSK Biologicals’
  • The present Phase 2, randomised, controlled trial will aim at collecting safety and immunogenicity data following a single intramuscular (IM) dose of the investigational ChAd3-EBO-Z vaccine. The study will be conducted in healthy children living in countries adjacent to the current Ebola outbreak zones.
  • 2015-10-02

Subscribe to Our Newsletter

About NCTR?

NCTR Initiative

The NCTR is a collaborative initiative of the National Agency for Food & Drugs Administration and Control, with support from the National Health Research Ethics Committee and the Federal Ministry of Health

Contact Us

Address: Federal Ministry of Health, Federal Secretariat Complex Shehu Shagari Way, Garki, Abuja
Email: info@nhrec.net